New vaccine for Epstein-Barr virus may cut risk of MS, various cancers
Researchers developed a vaccine for the Epstein-Barr virus (EBV), which is linked to a 32-fold higher risk of multiple sclerosis (MS).
They found that the vaccine induced a strong immune against EBV that lasted seven months in mice.
Further tests are needed to know how these findings may apply to humans.
A groundbreaking new vaccine for the Epstein-Barr virus may pave the way for better preventive and treatment options for conditions such as multiple sclerosis and various cancers.

Read more on:
https://www.medicalnewstoday.com/articles/new-epstein-barr-virus-vaccine-reduce-ms-cancer-risks